Eltayeb v. Akron Nephrology Assoc.

2025 Ohio 248
Ohio Court of Appeals·Decided January 29, 2025·No. 30992·Published

Opinion

STATE OF OHIO ) IN THE COURT OF APPEALS )ss: NINTH JUDICIAL DISTRICT COUNTY OF SUMMIT )

BABIKER ELTAYEB, M.D. C.A. No. 30992 Appellee

v. APPEAL FROM JUDGMENT ENTERED IN THE

AKRON NEPHROLOGY ASSOCIATES, COURT OF COMMON PLEAS INC. COUNTY OF SUMMIT, OHIO CASE No. CV-2017-06-2590 Appellant

DECISION AND JOURNAL ENTRY Dated: January 29, 2025

HENSAL, Judge.

{¶1} Akron Nephrology Associates, Inc. (“ANA”) appeals a judgment of the Summit County Court of Common Pleas that awarded $451,607.00 to Babiker Eltayeb, M.D. and an order that denied its motion for remittitur, denied its motion for new trial, and granted Dr. Eltayeb attorney fees. For the following reasons, this Court affirms.

I.

{¶2} Dr. Eltayeb began working for ANA in 1998 and eventually became a shareholder in the company. In March 2017, Dr. Eltayeb let his partners know that he was retiring from the practice. He, thereafter, sought a buyout of his shares under the terms of the shareholders agreement. ANA opposed the buyout because it did not believe Dr. Eltayeb had retired because he went to work in another country. Dr. Eltayeb sued ANA for breach of contract and two of his partners for breach of fiduciary duty. A jury found ANA liable for breach of contract and awarded Dr. Eltayeb $451,607 in damages. The trial court also awarded Dr. Eltayeb his attorney fees, in

accordance with the shareholders agreement, and prejudgment interest. ANA moved for remittitur or, in the alternative, for a new trial of the damages, arguing that the jury’s award was not supported by the evidence. The trial court, however, denied its motions. ANA has appealed, assigning four errors.

II.

ASSIGNMENT OF ERROR I

THE TRIAL COURT ERRED WHEN IT DENIED AKRON NEPHROLOGY’S MOTION FOR REMITTITUR AND ALTERNATIVE REQUEST FOR NEW TRIAL WHERE THERE WAS NO COMPETENT, SUBSTANTIAL, AND CREDIBLE EVIDENCE TO SUPPORT THE JURY’S VERDICT OF $451,607.00 ON ELTAYEB’S BREACH OF CONTRACT CLAIM.

{¶3} In its first assignment of error, ANA argues that the trial court should have granted its motion for remittitur or for new trial because the jury’s award is not supported by the evidence. It notes that Dr. Eltayeb argued that the retirement buyout price was $702,994, while it argued that the buyout price was $306,830.18. The jury awarded $451,607, however, which ANA argues is not supported by the evidence.

{¶4} Regarding ANA’s motion for remittitur, “courts have the inherent authority to order remittiturs to reduce jury awards when they deem the amount to be excessive based on facts found by the jury.” Arbino v. Johnson & Johnson, 2007-Ohio-6948, ¶ 38. “This Court reviews a trial court’s decision to deny remittitur for an abuse of discretion.” Jemson v. Falls Village Retirement Community, Ltd., 2002-Ohio-4155, ¶ 26 (9th Dist.).

{¶5} Regarding ANA’s motion for new trial, Civil Rule 59(A) provides that a new trial may be granted on the grounds of an “[e]rror in the amount of recovery, whether too large or too small” or if “[t]he judgment is not sustained by the weight of the evidence . . . .” Civ.R. 59(A)(5) & (6). If the basis of a motion for new trial “involves a question of law, the de novo standard of

review applies, and when the basis of the motion involves the determination of an issue left to the trial court’s discretion, the abuse of discretion standard applies.” Dragway 42, L.L.C. v. Kokosing Constr. Co., Inc., 2010-Ohio-4657, ¶ 32 (9th Dist.).

When considering a Civ.R. 59(A)(6) motion for a new trial, a trial court must weigh the evidence and pass on the credibility of the witnesses. Yet, the trial court assesses the weight and credibility in a more limited sense than would a jury; the court is to determine, in light of its broad discretion, whether a manifest injustice has occurred.

DiDonato v. Roig, 2024-Ohio-2109, ¶ 18 (9th Dist.), quoting Windward Ents., Inc. v. Valley City Dev. Group LLC, 2019-Ohio-3419, ¶ 18 (9th Dist.).

{¶6} “A claimant seeking to recover for breach of contract must show damage as a result of the breach.” Textron Fin. Corp. v. Nationwide Mut. Ins. Co., 115 Ohio App.3d 137, 144 (9th Dist. 1996). “Damages are not awarded for a mere breach of contract; the amount of damages awarded must correspond to injuries resulting from the breach.” Id. “As a general rule, an injured party cannot recover damages for breach of contract beyond the amount that is established by the evidence with reasonable certainty, and generally, courts have required greater certainty in the proof of damages for breach of contract than in tort.” Id., quoting Rhodes v. Rhodes Indus., Inc., 71 Ohio App.3d 797, 808-809 (8th Dist. 1991). “The damages awarded for a breach of contract should place the injured party in as good a position as it would have been in but for the breach.” Id. “Such compensatory damages, often termed ‘expectation damages,’ are limited to actual loss, which loss must be established with reasonable certainty.” Id.

{¶7} The shareholders agreement provided that the purchase price for the shares of a retiring shareholder would be “equal to the average annual compensation of full time Shareholders during the prior three (3) full calendar years . . . from the date of the [retirement] notice . . . [.]” The parties disagreed over the meaning of the term “compensation.” According to Dr. Eltayeb,

ANA had two sources of income. First, each of the doctors had a clinical practice consulting with patients at their office or a hospital. Second, the owner of multiple dialysis centers had hired ANA to provide physician services at its centers. Dr. Eltayeb testified that his compensation from ANA consisted of both his income from clinical visits and his share of the income from the dialysis centers. ANA, however, argued that a shareholder’s “compensation” only included a doctor’s clinical fees.

{¶8} ANA had three shareholders at the time of Dr. Eltayeb’s retirement. Dr. Eltayeb averaged the amount he claimed they each received in clinical and dialysis-center fees in 2014, 2015, and 2016, to reach his buyout-entitlement figure of $702,944. ANA, on the other hand, only averaged the shareholders’ clinical fees from 2014, 2015, and 2016, to calculate its buyout figure of $306,830.18

{¶9} Based on the evidence submitted, we conclude the jury award of $451,607 cannot be deemed excessive because it was less than Dr. Eltayeb could reasonably argue he was entitled to under the buyout provision of the shareholders agreement. Although there is no clear indication for why the jury settled on $451,607, we also cannot say that the amount is not supported by the weight of the evidence. Dr. Eltayeb presented evidence that would support a damage award up to and including the full amount he requested. We also note that ANA presented a copy of Dr. Eltayeb’s employment contract from his new employer. In determining how much Dr. Eltayeb was injured by ANA’s breach of contract, the jury may have considered his injury to have been mitigated by his compensation at his new employer, which Dr. Eltayeb testified was about $200,000 a year. Upon review of the record, we conclude that ANA has failed to establish that the trial court improperly exercised its discretion when it denied the motion for remittitur and motion for new trial. ANA’s first assignment of error is overruled.

ASSIGNMENT OF ERROR II

THE TRIAL COURT ERRED WHEN IT FAILED TO SUBMIT TO THE JURY AKRON NEPHROLOGY’S PROPOSED JURY INTERROGATORY NO. 3 (WHICH WOULD HAVE PREVENTED THE ERROR ADDRESS BY ASSIGNMENT OF ERROR NO. 1). IN VIOLATION OF OHIO RULE OF CIVIL PROCEDURE 49(B).

{¶10} In its second assignment of error, ANA argues that the trial court incorrectly refused to submit a jury interrogatory it requested to the jury. Civil Rule 49(B) provides that “[t]he court shall submit written interrogatories to the jury . . . upon request of any party prior to the commencement of argument.” “The interrogatories may be directed to one or more determinative issues whether issues of fact or mixed issues of fact and law.” Civ.R. 49(B).

Free access — add to your briefcase to read the full text and ask questions with AI

Eltayeb v. Akron Nephrology Assoc., 2025 Ohio 248 (Ohio Ct. App. 2025).

2025 Ohio 248 (Eltayeb v. Akron Nephrology Assoc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Arbino v. Johnson & Johnson
2007 Ohio 6948 (Ohio Supreme Court, 2007)
Moretz v. Muakkassa
2013 Ohio 4656 (Ohio Supreme Court, 2013)
Magnum Steel & Trading, L.L.C. v. Mink
2013 Ohio 2431 (Ohio Court of Appeals, 2013)
Rhodes v. Rhodes Industries, Inc.
595 N.E.2d 441 (Ohio Court of Appeals, 1991)
Cambridge Co., Ltd. v. Telsat, Inc., 23935 (3-12-2008)
2008 Ohio 1056 (Ohio Court of Appeals, 2008)
Textron Financial Corp. v. Nationwide Mutual Insurance
684 N.E.2d 1261 (Ohio Court of Appeals, 1996)
Burkett v. Cook, Unpublished Decision (9-12-2007)
2007 Ohio 4652 (Ohio Court of Appeals, 2007)
Hagemeyer v. Sadowski
621 N.E.2d 707 (Ohio Court of Appeals, 1993)
Weaner & Assos., L.L.C. v. 369 W. First St., L.L.C.
2016 Ohio 8077 (Ohio Court of Appeals, 2016)
Windward Ents., Inc. v. Valley City Dev. Group, L.L.C.
2019 Ohio 3419 (Ohio Court of Appeals, 2019)
Woodside Mgt. Co. v. Bruex
2020 Ohio 4039 (Ohio Court of Appeals, 2020)
Nottingdale Homeowners' Ass'n v. Darby
514 N.E.2d 702 (Ohio Supreme Court, 1987)
Bittner v. Tri-County Toyota, Inc.
569 N.E.2d 464 (Ohio Supreme Court, 1991)
Ziegler v. Wendel Poultry Services, Inc.
615 N.E.2d 1022 (Ohio Supreme Court, 1993)
Freeman v. Norfolk & Western Railway Co.
635 N.E.2d 310 (Ohio Supreme Court, 1994)
HB Martin Logistics, Inc. v. Hissong Group, Inc.
2023 Ohio 4836 (Ohio Court of Appeals, 2023)
Vitantonio v. Am. Constr. Group, L.L.C.
2024 Ohio 325 (Ohio Court of Appeals, 2024)
Loewe v. Loewe
2024 Ohio 323 (Ohio Court of Appeals, 2024)
DiDonato v. Roig
2024 Ohio 2109 (Ohio Court of Appeals, 2024)